ストックスクリーナーアプリを入手
17.07
1.31%
0.22
アフターアワーズ：
17.07
前日終値:
$16.85
開ける：
$16.78
24時間の取引高:
160.32K
Relative Volume:
0.86
時価総額：
$1.16B
収益：
-
当期純損益:
$-46.13M
株価収益率:
-21.01
EPS:
-0.8123
ネットキャッシュフロー:
$-34.10M
1週間 パフォーマンス:
-0.70%
1か月 パフォーマンス:
+9.63%
6か月 パフォーマンス:
-14.09%
1年 パフォーマンス:
+145.61%
1日の値動き範囲:
$16.59
$17.47
1週間の範囲:
$15.92
$17.54
52週間の値動き範囲:
$6.66
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
PLSE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
17.07 | 1.16B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-27 | 開始されました | Stephens | Overweight |
| 2021-03-11 | 開始されました | Maxim Group | Buy |
| 2021-01-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-12 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Pulse Biosciences Inc (PLSE) 最新ニュース
Barclays PLC Raises Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Reports Q1 2025 Financial Results - TipRanks
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Wells Fargo & Company MN Purchases 2,416 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Decoding Pulse Biosciences Inc (PLSE): A Strategic SWOT Insight - GuruFocus
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - BioSpace
Earnings Flash (PLSE) Pulse Biosciences Q1 Loss $0.25 Vs. $0.18 Loss Year Ago - marketscreener.com
Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up - Investing.com
PULSE BIOSCIENCES, INC. SEC 10-Q Report - TradingView
Pulse Biosciences Inc Reports Q1 2025 Financial Results: GAAP Net Loss of $16.8 Million, Cash Reserves at $119.3 Million - GuruFocus
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference - Business Wire
Pulse Biosciences (PLSE) Faces Criticism Over Technology's Past Performance | PLSE Stock News - GuruFocus
PLSE Faces Skepticism over Nano-Pulse Stimulation's Commercial V - GuruFocus
After the recent decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's holdings have lost 4.2% of their value - simplywall.st
Pulse Biosciences names Jon Skinner as new CFO - MSN
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting - Stock Titan
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by Legal & General Group Plc - Defense World
Head to Head Survey: Pulse Biosciences (NASDAQ:PLSE) & Sight Sciences (NASDAQ:SGHT) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Invesco Ltd. - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 25, 2025 - BioSpace
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 - BioSpace
Geode Capital Management LLC Increases Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 | PLSE Stock News - GuruFocus
Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its Business - Yahoo Finance
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting - The Joplin Globe
Revolutionary Nanosecond PFA Heart Treatment Takes Center Stage at HRS 2025: J&J Partnership Revealed - Stock Titan
Trading (PLSE) With Integrated Risk Controls - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 150,506 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Corebridge Financial Inc. Cuts Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
20,000 Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) Bought by Norges Bank - Defense World
KLP Kapitalforvaltning AS Buys Shares of 2,500 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences: Some Key Questions Remain Unanswered - Seeking Alpha
Pulse Biosciences at Needham Conference: Strategic Growth and Market Expansion - Investing.com UK
Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE) - Seeking Alpha
When (PLSE) Moves Investors should Listen - news.stocktradersdaily.com
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering - Business Wire
Pulse Biosciences (NASDAQ:PLSE) Upgraded to Sell at StockNews.com - Defense World
PULSE BIOSCIENCES, INC. SEC 10-K Report - TradingView
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript - MSN
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up – What’s Next? - Defense World
Pulse Biosciences Insiders Placed Bullish Bets Worth US$2.79m - simplywall.st
Pulse Biosciences Earnings Call: Progress Amid Challenges - TipRanks
Pulse Biosciences Inc Reports Q4 2024 GAAP Net Loss of $19.4 Mil - GuruFocus
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results - TradingView
Charles Schwab Investment Management Inc. Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs - Yahoo Finance
Pulse Biosciences Inc (PLSE) 財務データ
収益
当期純利益
現金流量
EPS
5.40%
0.78%
大文字化:
|
ボリューム (24 時間):